51. Does current ovarian endometrioma increase the time for DOR patients to reach live birth in IVF?
- Author
-
Deng, Yu, Ou, Zhanhui, Yin, Minna, Chen, Zhiheng, Chen, Shiling, and Sun, Ling
- Subjects
- *
OVARIAN cancer , *HUMAN in vitro fertilization , *ENDOMETRIOSIS , *FERTILIZATION in vitro , *OVARIAN reserve , *ANTI-Mullerian hormone , *FERRANS & Powers Quality of Life Index , *BIRTH rate , *CASE-control method , *RETROSPECTIVE studies , *PREGNANCY outcomes , *EMBRYO transfer , *RESEARCH funding , *INDUCED ovulation - Abstract
Background: The contents of ovarian endometrioma (OMA) such as inflammatory mediators, reactive oxygen species, and iron may disrupt normal folliculogenesis and result in subsequent oocyte apoptosis. Therefore, women with OMA have a potential risk of diminished ovarian reserve (DOR). The purpose of this study is to compare the in vitro fertilization (IVF) outcomes and efficiency between DOR patients with and without current OMA.Methods: This retrospective case-control study included a total of 493 women with DOR (serum anti-Müllerian hormone level < 1.1 ng/mL). Ninety patients with OMA (Group A) underwent 191 IVF cycles and 403 patients without ovarian OMA (Group B) underwent 888 IVF cycles in our center between January 2014 and December 2018. Basal characteristics and IVF outcomes were compared between Group A and Group B. Time to achieve live birth were compared between patients with live birth in two groups (Group A1, 31 patients; Group B1, 132 patients).Results: Clinical and demographic characteristics of patients were similar respectively between groups (A vs. B, A1 vs. B1). There were no statistically significant differences in implantation rate, live birth rate per OPU and per ET cycle and the cumulative live birth rate per patient and per patient with good-quality embryos between Group A and Group B (P > 0.05). Total time to achieve live birth has no statistically significant difference between Group A1 and Group B1 (P > 0.05).Conclusion: For DOR women, presence of endometrioma did not affect the IVF outcomes. Even the time to get live birth was not prolonged by current OMA. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF